These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1420 related articles for article (PubMed ID: 23298828)

  • 41. The surgical treatment of a melanoma patient with macroscopic metastasis in peri and retrocaval lymph nodes and with a positive sentinel lymph node in the groin.
    Giudice G; Robusto F; Nacchiero E
    Ann Ital Chir; 2016 Feb; 87(ePub):. PubMed ID: 26903177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: A comparison of the size of metastasis detected in inguinal lymph nodes.
    Robison K; Steinhoff MM; Granai CO; Brard L; Gajewski W; Moore RG
    Gynecol Oncol; 2006 Apr; 101(1):24-7. PubMed ID: 16246399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study.
    Feldmann R; Fink AM; Jurecka W; Rappersberger K; Steiner A
    Eur J Surg Oncol; 2014 Jan; 40(1):73-6. PubMed ID: 24075029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma.
    van Akkooi AC; Bouwhuis MG; van Geel AN; Hoedemaker R; Verhoef C; Grunhagen DJ; Schmitz PI; Eggermont AM; de Wilt JH
    Eur J Surg Oncol; 2007 Feb; 33(1):102-8. PubMed ID: 17161577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic information from sentinel lymph node biopsy in patients with thick melanoma.
    Scoggins CR; Bowen AL; Martin RC; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; Hagendoorn L; McMasters KM
    Arch Surg; 2010 Jul; 145(7):622-7. PubMed ID: 20644123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of primary melanoma thickness and microscopic tumor burden in sentinel lymph nodes on melanoma patient survival.
    Baehner FL; Li R; Jenkins T; Hwang J; Kashani-Sabet M; Allen RE; Leong SP
    Ann Surg Oncol; 2012 Mar; 19(3):1034-42. PubMed ID: 21989664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients.
    Howman-Giles R; Shaw HM; Scolyer RA; Murali R; Wilmott J; McCarthy SW; Uren RF; Thompson JF
    Ann Surg Oncol; 2010 Jan; 17(1):138-43. PubMed ID: 19672660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.
    Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
    Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for a better nodal staging system for melanoma: the clinical relevance of metastatic disease confined to the sentinel lymph nodes.
    Reintgen M; Murray L; Akman K; Giuliano R; Lozicki A; Shivers S; Reintgen D
    Ann Surg Oncol; 2013 Feb; 20(2):668-74. PubMed ID: 23054112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
    Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
    Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic heterogeneity after the excision of lymph node metastases in patients with cutaneous melanoma.
    Pilko G; Besic N; Zgajnar J; Hocevar M
    Surg Oncol; 2011 Mar; 20(1):26-34. PubMed ID: 19900803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of the lymph nodes in penile cancer.
    Heyns CF; Fleshner N; Sangar V; Schlenker B; Yuvaraja TB; van Poppel H
    Urology; 2010 Aug; 76(2 Suppl 1):S43-57. PubMed ID: 20691885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
    Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
    Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 71.